Table of Contents Author Guidelines Submit a Manuscript
RETRACTED

This article has been retracted as it was found to contain a substantial amount of material from the following published article: “Plasmablastic Lymphoma: A Systematic Review” by Jorge J. Castillo and John L. Reagan, in The Scientific World Journal.

Advances in Hematology
Volume 2015 (2015), Article ID 315289, 11 pages
http://dx.doi.org/10.1155/2015/315289
Review Article

Plasmablastic Lymphoma: A Review of Current Knowledge and Future Directions

1Department of Pathology and Blood Bank, Prince Sultan Military Medical City, P.O. Box 7897, Riyadh 11159, Saudi Arabia
2Department of Hematology, Theodor Bilharz Research Institute, Egypt
3Hematopathology Division, Department of Basic Science, College of Medicine, Princess Nourah Bint Abdulrahman University, Riyadh, Saudi Arabia
4Department of Oncology, Prince Sultan Military Medical City, Saudi Arabia

Received 16 May 2015; Revised 29 July 2015; Accepted 3 August 2015

Academic Editor: Elvira Grandone

Copyright © 2015 Ghaleb Elyamany et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. H. J. Delecluse, I. Anagnostopoulos, F. Dallenbach et al., “Plasmablastic lymphomas of the oral cavity: a new entity associated with the human immunodeficiency virus infection,” Blood, vol. 89, no. 4, pp. 1413–1420, 1997. View at Google Scholar · View at Scopus
  2. N. Medel and A. Hamao-Sakamoto, “A case of oral plasmablastic lymphoma and review of current trends in oral manifestations associated with human immunodeficiency virus infection,” Journal of Oral and Maxillofacial Surgery, vol. 72, no. 9, pp. 1729–1735, 2014. View at Publisher · View at Google Scholar · View at Scopus
  3. H. Stein, N. L. Harris, and E. Campo, “Plasmablastic lymphoma,” in WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues, S. H. Swerdlow, E. Campo, N. L. Harris et al., Eds., pp. 256–257, IARC Press, Lyon, France, 4th edition, 2008. View at Google Scholar
  4. O.-J. Lee, K.-W. Kim, and G. K. Lee, “Epstein-Barr virus and human immunodeficiency virus-negative oral plasmablastic lymphoma,” Journal of Oral Pathology & Medicine, vol. 35, no. 6, pp. 382–384, 2006. View at Publisher · View at Google Scholar · View at Scopus
  5. J. J. Liu, L. Zhang, E. Ayala et al., “Human immunodeficiency virus (HIV)-negative plasmablastic lymphoma: a single institutional experience and literature review,” Leukemia Research, vol. 35, no. 12, pp. 1571–1577, 2011. View at Publisher · View at Google Scholar · View at Scopus
  6. J. J. Castillo and J. L. Reagan, “Plasmablastic lymphoma: a systematic review,” TheScientificWorldJournal, vol. 11, pp. 687–696, 2011. View at Publisher · View at Google Scholar · View at Scopus
  7. N. S. Saba, D. Dang, J. Saba et al., “Bortezomib in plasmablastic lymphoma: a case report and review of the literature,” Onkologie, vol. 36, no. 5, pp. 287–291, 2013. View at Publisher · View at Google Scholar · View at Scopus
  8. Y. Lin, G. D. Rodrigues, J. F. Turner, and M. A. Vasef, “Plasmablastic lymphoma of the lung: report of a unique case and review of the literature,” Archives of Pathology and Laboratory Medicine, vol. 125, no. 2, pp. 282–285, 2001. View at Google Scholar · View at Scopus
  9. R. Chetty, N. Hlatswayo, R. Muc, R. Sabaratnam, and K. Gatter, “Plasmablastic lymphoma in HIV+ patients: an expanding spectrum,” Histopathology, vol. 42, no. 6, pp. 605–609, 2003. View at Publisher · View at Google Scholar · View at Scopus
  10. S. A. Schichman, R. McClure, R. F. Schaefer, and P. Mehta, “HIV and plasmablastic lymphoma manifesting in sinus, testicles, and bones: a further expansion of the disease spectrum,” American Journal of Hematology, vol. 77, no. 3, pp. 291–295, 2004. View at Publisher · View at Google Scholar · View at Scopus
  11. H. Y. Dong, D. T. Scadden, L. de Leval, Z. Tang, P. G. Isaacson, and N. L. Harris, “Plasmablastic lymphoma in HIV-positive patients: an aggressive Epstein-Barr virus-associated extramedullary plasmacytic neoplasm,” The American Journal of Surgical Pathology, vol. 29, no. 12, pp. 1633–1641, 2005. View at Publisher · View at Google Scholar · View at Scopus
  12. L. B. Jordan, A. M. Lessells, and J. R. Goodlad, “Plasmablastic lymphoma arising at a cutaneous site,” Histopathology, vol. 46, no. 1, pp. 113–115, 2005. View at Publisher · View at Google Scholar · View at Scopus
  13. J.-P. Dales, A. Harket, D. Bagnères et al., “Plasmablastic lymphoma in a patient with HIV infection: an unusual case located in the skin,” Annales de Pathologie, vol. 25, no. 1, pp. 45–49, 2005 (French). View at Publisher · View at Google Scholar · View at Scopus
  14. J. Ojanguren, J. Collazos, C. Martínez, J. Alvarez, and J. Mayo, “Epstein-Barr virus-related plasmablastic lymphomas arising from long-standing sacrococcygeal cysts in immunosuppressed patients,” AIDS, vol. 17, no. 10, pp. 1582–1584, 2003. View at Google Scholar · View at Scopus
  15. P. R. Raviele, G. Pruneri, and E. Maiorano, “Plasmablastic lymphoma: a review,” Oral Diseases, vol. 15, no. 1, pp. 38–45, 2009. View at Publisher · View at Google Scholar · View at Scopus
  16. J. Castillo, L. Pantanowitz, and B. J. Dezube, “HIV-associated plasmablastic lymphoma: lessons learned from 112 published cases,” American Journal of Hematology, vol. 83, no. 10, pp. 804–809, 2008. View at Publisher · View at Google Scholar · View at Scopus
  17. S. A. Jaffar, G. Pihan, B. J. Dezube, and L. Pantanowitz, “Differentiating HIV-associated lymphomas that exhibit plasmacellular differentiation,” HIV and AIDS Review, vol. 4, no. 3, pp. 43–49, 2005. View at Google Scholar · View at Scopus
  18. C. Thakral, L. Thomas, A. Gajra, R. E. Hutchison, G. C. Ravizzini, and N. Vajpayee, “Plasmablastic lymphoma in an immunocompetent patient,” Journal of Clinical Oncology, vol. 27, no. 25, pp. e78–e81, 2009. View at Publisher · View at Google Scholar · View at Scopus
  19. C.-C. Chang, X. Zhou, J. J. Taylor et al., “Genomic profiling of plasmablastic lymphoma using array comparative genomic hybridization (aCGH): revealing significant overlapping genomic lesions with diffuse large B-cell lymphoma,” Journal of Hematology and Oncology, vol. 2, article 47, 2009. View at Publisher · View at Google Scholar · View at Scopus
  20. F. Vega, C. C. Chang, L. J. Medeiros et al., “Plasmablastic lymphomas and plasmablastic plasma cell myelomas have nearly identical immunophenotypic profiles,” Modern Pathology, vol. 18, no. 6, pp. 806–815, 2005. View at Publisher · View at Google Scholar
  21. R. Lester, C. H. Li, P. Phillips et al., “Improved outcome of human immunodeficiency virus-associated plasmablastic lymphoma of the oral cavity in the era of highly active antiretroviral therapy: a report of two cases,” Leukemia and Lymphoma, vol. 45, no. 9, pp. 1881–1885, 2004. View at Publisher · View at Google Scholar · View at Scopus
  22. G. Panos, E. A. Karveli, O. Nikolatou, and M. E. Falagas, “Prolonged survival of an HIV-infected patient with plasmablastic lymphoma of the oral cavity,” The American Journal of Hematology, vol. 82, no. 8, pp. 761–765, 2007. View at Publisher · View at Google Scholar · View at Scopus
  23. J. J. Castillo, M. Bibas, and R. N. Miranda, “The biology and treatment of plasmablastic lymphoma,” Blood, vol. 125, no. 15, pp. 2323–2330, 2015. View at Publisher · View at Google Scholar
  24. J. Morscio, D. Dierickx, J. Nijs et al., “Clinicopathologic comparison of plasmablastic lymphoma in HIV-positive, immunocompetent, and posttransplant patients: single-center series of 25 cases and meta-analysis of 277 reported cases,” The American Journal of Surgical Pathology, vol. 38, no. 7, pp. 875–886, 2014. View at Publisher · View at Google Scholar · View at Scopus
  25. K. G. Babu, M. C. S. Babu, L. J. Abraham et al., “Plasmablastic lymphoma: does prognosis differ with HIV status and site of disease?” Oncology, Gastroenterology and Hepatology Reports, vol. 3, no. 2, pp. 25–29, 2014. View at Publisher · View at Google Scholar
  26. J. J. Castillo, E. S. Winer, D. Stachurski et al., “Clinical and pathological differences between human immunodeficiency virus-positive and human immunodeficiency virus-negative patients with plasmablastic lymphoma,” Leukemia and Lymphoma, vol. 51, no. 11, pp. 2047–2053, 2010. View at Publisher · View at Google Scholar · View at Scopus
  27. L. Colomo, F. Loong, S. Rives et al., “Diffuse large B-cell lymphomas with plasmablastic differentiation represent a heterogeneous group of disease entities,” American Journal of Surgical Pathology, vol. 28, no. 6, pp. 736–747, 2004. View at Publisher · View at Google Scholar · View at Scopus
  28. J. E. Kim, Y. A. Kim, W. Y. Kim et al., “Human immunodeficiency virus-negative plasmablastic lymphoma in Korea,” Leukemia and Lymphoma, vol. 50, no. 4, pp. 582–587, 2009. View at Publisher · View at Google Scholar · View at Scopus
  29. M. A. Scheper, N. G. Nikitakis, R. Fernandes, C. D. Gocke, R. A. Ord, and J. J. Sauk, “Oral plasmablastic lymphoma in an HIV-negative patient: a case report and review of the literature,” Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology and Endodontology, vol. 100, no. 2, pp. 198–206, 2005. View at Publisher · View at Google Scholar · View at Scopus
  30. J. Teruya-Feldstein, E. Chiao, D. A. Filippa et al., “CD20-negative large-cell lymphoma with plasmablastic features: a clinically heterogenous spectrum in both HIV-positive and -negative patients,” Annals of Oncology, vol. 15, no. 11, pp. 1673–1679, 2004. View at Publisher · View at Google Scholar · View at Scopus
  31. A. Carbone and A. Gloghini, “Plasmablastic lymphoma: one or more entities?” American Journal of Hematology, vol. 83, no. 10, pp. 763–764, 2008. View at Publisher · View at Google Scholar · View at Scopus
  32. G. S. Folk, S. L. Abbondanzo, E. L. Childers, and R. D. Foss, “Plasmablastic lymphoma: a clinicopathologic correlation,” Annals of Diagnostic Pathology, vol. 10, no. 1, pp. 8–12, 2006. View at Publisher · View at Google Scholar · View at Scopus
  33. M. Bibas and J. J. Castillo, “Current knowledge on HIV-associated plasmablastic lymphoma,” Mediterranean Journal of Hematology and Infectious Diseases, vol. 6, no. 1, Article ID e2014064, 2014. View at Publisher · View at Google Scholar
  34. S. Apichai, A. Rogalska, I. Tzvetanov, Z. Asma, E. Benedetti, and S. Gaitonde, “Multifocal cutaneous and systemic plasmablastic lymphoma in an infant with combined living donor small bowel and liver transplant,” Pediatric Transplantation, vol. 13, no. 5, pp. 628–631, 2009. View at Publisher · View at Google Scholar · View at Scopus
  35. P. Chabay, E. De Matteo, M. Lorenzetti et al., “Vulvar plasmablastic lymphoma in a HIV-positive child: a novel extraoral localisation,” Journal of Clinical Pathology, vol. 62, no. 7, pp. 644–646, 2009. View at Publisher · View at Google Scholar · View at Scopus
  36. A. Gogia and S. Bakhshi, “Plasmablastic lymphoma of oral cavity in a HIV-negative child,” Pediatric Blood & Cancer, vol. 55, no. 2, pp. 390–391, 2010. View at Publisher · View at Google Scholar · View at Scopus
  37. C. Hernandez, A. S. Cetner, and E. L. Wiley, “Cutaneous presentation of plasmablastic post-transplant lymphoproliferative disorder in a 14-month-old,” Pediatric Dermatology, vol. 26, no. 6, pp. 713–716, 2009. View at Publisher · View at Google Scholar · View at Scopus
  38. R. Radhakrishnan, S. Suhas, R. V. Kumar, G. Krishnanand, R. Srinivasan, and N. N. Rao, “Plasmablastic lymphoma of the oral cavity in an HIV-positive child,” Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology and Endodontology, vol. 100, no. 6, pp. 725–731, 2005. View at Publisher · View at Google Scholar · View at Scopus
  39. J. J. Castillo, E. S. Winer, D. Stachurski et al., “HIV-negative plasmablastic lymphoma: not in the mouth,” Clinical Lymphoma, Myeloma and Leukemia, vol. 11, no. 2, pp. 185–189, 2011. View at Publisher · View at Google Scholar · View at Scopus
  40. A. Sharma, T. V. S. V. G. K. Tilak, R. Lodha, M. C. Sharma, and D. Dabkara, “Long-term survivor of human immunodeficiency virus-associated plasmablastic lymphoma,” Indian Journal of Medical and Paediatric Oncology, vol. 34, no. 2, pp. 96–98, 2013. View at Publisher · View at Google Scholar · View at Scopus
  41. J. I. Vaubell, Y. Sing, A. Ramburan et al., “Pediatric plasmablastic lymphoma: a clinicopathologic study,” International Journal of Surgical Pathology, vol. 22, no. 7, pp. 607–616, 2014. View at Publisher · View at Google Scholar · View at Scopus
  42. S. Pather, D. MacKinnon, and R. S. Padayachee, “Plasmablastic lymphoma in pediatric patients: clinicopathologic study of three cases,” Annals of Diagnostic Pathology, vol. 17, no. 1, pp. 80–84, 2013. View at Publisher · View at Google Scholar · View at Scopus
  43. S. C. Sarode, G. S. Sarode, and A. Patil, “Plasmablastic lymphoma of the oral cavity: a review,” Oral Oncology, vol. 46, no. 3, pp. 146–153, 2010. View at Publisher · View at Google Scholar · View at Scopus
  44. A. Carbone, “Emerging pathways in the development of AIDS-related lymphomas,” The Lancet Oncology, vol. 4, no. 1, pp. 22–29, 2003. View at Publisher · View at Google Scholar · View at Scopus
  45. S. Montes-Moreno, A.-R. Gonzalez-Medina, S.-M. Rodriguez-Pinilla et al., “Aggressive large B-cell lymphoma with plasma cell differentiation: immunohistochemical characterization of plasmablastic lymphoma and diffuse large B-cell lymphoma with partial plasmablastic phenotype,” Haematologica, vol. 95, no. 8, pp. 1342–1349, 2010. View at Publisher · View at Google Scholar · View at Scopus
  46. M. Bibas and A. Antinori, “EBV and HIV-related lymphoma,” Mediterranean Journal of Hematology and Infectious Diseases, vol. 1, no. 2, Article ID e2009032, 2009. View at Publisher · View at Google Scholar
  47. S. C. Boy, M. B. van Heerden, C. Babb, W. F. van Heerden, and P. Willem, “Dominant genetic aberrations and coexistent EBV infection in HIV-related oral plasmablastic lymphomas,” Oral Oncology, vol. 47, no. 9, pp. 883–887, 2011. View at Publisher · View at Google Scholar · View at Scopus
  48. J. J. Castillo, M. Furman, B. E. Beltrán et al., “Human immunodeficiency virus-associated plasmablastic lymphoma: poor prognosis in the era of highly active antiretroviral therapy,” Cancer, vol. 118, no. 21, pp. 5270–5277, 2012. View at Publisher · View at Google Scholar · View at Scopus
  49. A. Carbone, E. Cesarman, M. Spina, A. Gloghini, and T. F. Schulz, “HIV-associated lymphomas and gamma-herpesviruses,” Blood, vol. 113, no. 6, pp. 1213–1224, 2009. View at Publisher · View at Google Scholar · View at Scopus
  50. A. Carbone and A. Gloghini, “KSHV/HHV8-associated lymphomas,” British Journal of Haematology, vol. 140, no. 1, pp. 13–24, 2008. View at Publisher · View at Google Scholar · View at Scopus
  51. A. M. Cioc, C. Allen, J. R. Kalmar, S. Suster, R. Baiocchi, and G. J. Nuovo, “Oral plasmablastic lymphomas in AIDS patients are associated with human herpesvirus 8,” The American Journal of Surgical Pathology, vol. 28, no. 1, pp. 41–46, 2004. View at Publisher · View at Google Scholar · View at Scopus
  52. S. Verma, G. J. Nuovo, P. Porcu, R. A. Baiocchi, A. N. Crowson, and C. M. Magro, “Epstein-Barr virus- and human herpesvirus 8-associated primary cutaneous plasmablastic lymphoma in the setting of renal transplantation,” Journal of Cutaneous Pathology, vol. 32, no. 1, pp. 35–39, 2005. View at Publisher · View at Google Scholar · View at Scopus
  53. R. S. D. Brown, D. A. Power, H. F. Spittle, and K. J. Lankester, “Absence of immunohistochemical evidence for human herpesvirus 8 (HHV8) in oral cavity plasmablastic lymphoma in an HIV-positive man,” Clinical Oncology, vol. 12, article 194, 2000. View at Google Scholar · View at Scopus
  54. P. G. Isaacson, E. Campo, and N. L. Harris, “Large B-cell lymphoma arising in HHV8-associated multicentric Castleman disease,” in WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues, S. H. Swerdlow, E. Campo, N. L. Harris et al., Eds., IARC Press, Lyon, France, 4th edition, 2008. View at Google Scholar
  55. A. Valera, O. Balagué, L. Colomo et al., “IG/MYC rearrangements are the main cytogenetic alteration in plasmablastic lymphomas,” The American Journal of Surgical Pathology, vol. 34, no. 11, pp. 1686–1694, 2010. View at Publisher · View at Google Scholar · View at Scopus
  56. S. Janz, M. Potter, and C. S. Rabkin, “Lymphoma- and leukemia-associated chromosomal translocations in healthy individuals,” Genes Chromosomes and Cancer, vol. 36, no. 3, pp. 211–223, 2003. View at Publisher · View at Google Scholar · View at Scopus
  57. J. L. Arbiser, K. P. Mann, E. M. Losken et al., “Presence of p16 hypermethylation and Epstein-Barr virus infection in transplant-associated hematolymphoid neoplasm of the skin,” Journal of the American Academy of Dermatology, vol. 55, no. 5, pp. 794–798, 2006. View at Publisher · View at Google Scholar · View at Scopus
  58. A. Hassan, F. Kreisel, L. Gardner, J. S. Lewis Jr., and S. K. El-Mofty, “Plasmablastic lymphoma of head and neck: report of two new cases and correlation with c-myc and IgVH gene mutation status,” Head and Neck Pathology, vol. 1, no. 2, pp. 150–155, 2007. View at Publisher · View at Google Scholar · View at Scopus
  59. S. Shuangshoti, T. Assanasen, S. Lerdlum, T. Srikijvilaikul, T. Intragumtornchai, and P. S. Thorner, “Primary central nervous system plasmablastic lymphoma in AIDS,” Neuropathology and Applied Neurobiology, vol. 34, no. 2, pp. 245–247, 2008. View at Publisher · View at Google Scholar · View at Scopus
  60. C. Ustun, M. Reid-Nicholson, A. Nayak-Kapoor et al., “Plasmablastic lymphoma: CNS involvement, coexistence of other malignancies, possible viral etiology, and dismal outcome,” Annals of Hematology, vol. 88, no. 4, pp. 351–358, 2009. View at Publisher · View at Google Scholar · View at Scopus
  61. S. C. Sarode, G. A. Zarkar, R. S. Desai, V. S. Sabane, and M. A. Kulkarni, “Plasmablastic lymphoma of the oral cavity in an HIV-positive patient: a case report and review of literature,” International Journal of Oral and Maxillofacial Surgery, vol. 38, no. 9, pp. 993–999, 2009. View at Publisher · View at Google Scholar · View at Scopus
  62. A. M. Bogusz, A. C. Seegmiller, R. Garcia, P. Shang, R. Ashfaq, and W. Chen, “Plasmablastic lymphomas with MYC/IgH rearrangement: report of three cases and review of the literature,” American Journal of Clinical Pathology, vol. 132, no. 4, pp. 597–605, 2009. View at Publisher · View at Google Scholar · View at Scopus
  63. D. Hansra, N. Montague, A. Stefanovic et al., “Oral and extraoral plasmablastic lymphoma: similarities and differences in clinicopathologic characteristics,” The American Journal of Clinical Pathology, vol. 134, no. 5, pp. 710–719, 2010. View at Publisher · View at Google Scholar · View at Scopus
  64. S. Kane, A. Khurana, G. Parulkar et al., “Minimum diagnostic criteria for plasmablastic lymphoma of oral/sinonasal region encountered in a tertiary cancer hospital of a developing country,” Journal of Oral Pathology and Medicine, vol. 38, no. 1, pp. 138–144, 2009. View at Publisher · View at Google Scholar · View at Scopus
  65. A. Carbone, E. Vaccher, A. Gloghini et al., “Diagnosis and management of lymphomas and other cancers in HIV-infected patients,” Nature Reviews Clinical Oncology, vol. 11, no. 4, pp. 223–238, 2014. View at Publisher · View at Google Scholar · View at Scopus
  66. A. Tzankov, T. Brunhuber, A. Gschwendtner, and A. Brunner, “Incidental oral plasmablastic lymphoma with aberrant expression of CD4 in an elderly HIV-negative patient: how a gingival polyp can cause confusion,” Histopathology, vol. 46, no. 3, pp. 348–350, 2005. View at Publisher · View at Google Scholar · View at Scopus
  67. G. Elyamany, A. M. Alzahrani, M. Aljuboury et al., “Clinicopathologic features of plasmablastic lymphoma: single-center series of 8 cases from Saudi Arabia,” Diagnostic Pathology, vol. 10, no. 1, article 78, 2015. View at Publisher · View at Google Scholar
  68. A. S. Fiorino and B. Atac, “Paraproteinemia, plasmacytoma, myeloma and HIV infection,” Leukemia, vol. 11, no. 12, pp. 2150–2156, 1997. View at Publisher · View at Google Scholar · View at Scopus
  69. S. Kumar, D. Kumar, V. J. Schnadig, P. Selvanayagam, and D. P. Slaughter, “Plasma cell myeloma in patients who are HIV-positive,” American Journal of Clinical Pathology, vol. 102, no. 5, pp. 633–639, 1994. View at Google Scholar · View at Scopus
  70. S. D. Nasta, G. M. Carrum, I. Shahab, N. A. Hanania, and M. M. Udden, “Regression of a plasmablastic lymphoma in a patient with HIV on highly active antiretroviral therapy,” Leukemia & Lymphoma, vol. 43, no. 2, pp. 423–426, 2002. View at Publisher · View at Google Scholar · View at Scopus
  71. N. Mounier, M. Spina, J. Gabarre et al., “AIDS-related non-Hodgkin lymphoma: final analysis of 485 patients treated with risk-adapted intensive chemotherapy,” Blood, vol. 107, no. 10, pp. 3832–3840, 2006. View at Publisher · View at Google Scholar · View at Scopus
  72. J. J. Castillo, “Plasmablastic lymphoma: are more intensive regimens needed?” Leukemia Research, vol. 35, no. 12, pp. 1547–1548, 2011. View at Publisher · View at Google Scholar · View at Scopus
  73. J. J. Castillo, E. S. Winer, D. Stachurski et al., “Prognostic factors in chemotherapy-treated patients with HIV-associated plasmablastic lymphoma,” The Oncologist, vol. 15, no. 3, pp. 293–299, 2010. View at Publisher · View at Google Scholar · View at Scopus
  74. C. Saraceni, N. Agostino, D. B. Cornfield, and R. Gupta, “Plasmablastic lymphoma of the maxillary sinus in an HIV-negative patient: a case report and literature review,” SpringerPlus, vol. 2, no. 1, article 142, 2013. View at Publisher · View at Google Scholar · View at Scopus
  75. NCCN Practice Guidelines in Oncology, AIDS-related B-cell lymphomas (AIDS-2), November 2010, http://www.nccn.org/professionals/physician_gls/PDF/nhl.pdf.
  76. National Comprehensive Cancer Network guidelines in Oncology NHL version 2, 2014, http://www.nccn.org/professionals/physician_gls/pdf/nhl.pdf.
  77. M. M. Al-Malki, J. J. Castillo, J. M. Sloan, and A. Re, “Hematopoietic cell transplantation for plasmablastic lymphoma: a review,” Biology of Blood and Marrow Transplantation, vol. 20, no. 12, pp. 1877–1884, 2014. View at Publisher · View at Google Scholar · View at Scopus
  78. K. Dunleavy and W. H. Wilson, “How I treat HIV-associated lymphoma,” Blood, vol. 119, no. 14, pp. 3245–3255, 2012. View at Publisher · View at Google Scholar · View at Scopus
  79. R. Armstrong, J. Bradrick, and Y.-C. Liu, “Spontaneous regression of an HIV-associated plasmablastic lymphoma in the oral cavity: a case report,” Journal of Oral and Maxillofacial Surgery, vol. 65, no. 7, pp. 1361–1364, 2007. View at Publisher · View at Google Scholar · View at Scopus
  80. M. Gilaberte, F. Gallardo, B. Bellosillo et al., “Recurrent and self-healing cutaneous monoclonal plasmablastic infiltrates in a patient with AIDS and Kaposi sarcoma,” British Journal of Dermatology, vol. 153, no. 4, pp. 828–832, 2005. View at Publisher · View at Google Scholar · View at Scopus
  81. C. Cao, T. Liu, H. Zhu, L. Wang, S. Kai, and B. Xiang, “Bortezomib-contained chemotherapy and thalidomide combined with CHOP (Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone) play promising roles in plasmablastic lymphoma: a case report and literature review,” Clinical Lymphoma Myeloma and Leukemia, vol. 14, no. 5, pp. e145–e150, 2014. View at Publisher · View at Google Scholar
  82. M. Yan, Z. Dong, F. Zhao et al., “CD20-positive plasmablastic lymphoma with excellent response to bortezomib combined with rituximab,” European Journal of Haematology, vol. 93, no. 1, pp. 77–80, 2014. View at Publisher · View at Google Scholar · View at Scopus
  83. C. A. Dasanu, F. Bauer, I. Codreanu, P. Padmanabhan, and M. Rampurwala, “Plasmablastic haemato-lymphoid neoplasm with a complex genetic signature of Burkitt lymphoma responding to bortezomib,” Hematological Oncology, vol. 31, no. 3, pp. 164–166, 2013. View at Publisher · View at Google Scholar · View at Scopus
  84. M. Lipstein, O. O'Connor, F. Montanari, L. Paoluzzi, D. Bongero, and G. Bhagat, “Bortezomib-induced tumor lysis syndrome in a patient with HIV-negative plasmablastic lymphoma,” Clinical Lymphoma, Myeloma & Leukemia, vol. 10, no. 5, pp. E43–E46, 2010. View at Publisher · View at Google Scholar · View at Scopus
  85. P. Bose, C. Thompson, D. Gandhi, B. Ghabach, and H. Ozer, “AIDS-related plasmablastic lymphoma with dramatic, early response to bortezomib,” European Journal of Haematology, vol. 82, no. 6, pp. 490–492, 2009. View at Publisher · View at Google Scholar · View at Scopus
  86. M. Bibas, S. Grisetti, L. Alba, G. Picchi, F. Del Nonno, and A. Antinori, “Patient with HIV-associated plasmablastic lymphoma responding to bortezomib alone and in combination with dexamethasone, gemcitabine, oxaliplatin, cytarabine, and pegfilgrastim chemotherapy and lenalidomide alone,” Journal of Clinical Oncology, vol. 28, no. 34, pp. e704–e708, 2010. View at Publisher · View at Google Scholar · View at Scopus
  87. P. H. Wiernik, I. S. Lossos, J. M. Tuscano et al., “Lenalidomide monotherapy in relapsed or refractory aggressive non-Hodgkin's lymphoma,” Journal of Clinical Oncology, vol. 26, no. 30, pp. 4952–4957, 2008. View at Publisher · View at Google Scholar · View at Scopus
  88. R. J. Brentjens and K. J. Curran, “Novel cellular therapies for leukemia: CAR-modified T cells targeted to the CD19 antigen,” Hematology, vol. 2012, no. 1, pp. 143–151, 2012. View at Publisher · View at Google Scholar
  89. C. J. Turtle, “Chimeric antigen receptor modified T cell therapy for B cell malignancies,” International Journal of Hematology, vol. 99, no. 2, pp. 132–140, 2014. View at Publisher · View at Google Scholar · View at Scopus
  90. A. Jorritsma, R. Schotte, M. Coccoris, M. A. de Witte, and T. N. M. Schumacher, “Prospects and limitations of T cell receptor gene therapy,” Current Gene Therapy, vol. 11, no. 4, pp. 276–287, 2011. View at Publisher · View at Google Scholar · View at Scopus
  91. B. M. Holderness, S. Malhotra, N. B. Levy, and A. V. Danilov, “Brentuximab vedotin demonstrates activity in a patient with plasmablastic lymphoma arising from a background of chronic lymphocytic leukemia,” Journal of Clinical Oncology, vol. 31, no. 12, pp. e197–e199, 2013. View at Publisher · View at Google Scholar · View at Scopus
  92. J. J. Castillo, J. L. Reagan, W. M. Sikov, and E. S. Winer, “Bortezomib in combination with infusional dose-adjusted EPOCH for the treatment of plasmablastic lymphoma,” British Journal of Haematology, vol. 169, no. 3, pp. 352–355, 2015. View at Publisher · View at Google Scholar · View at Scopus
  93. M. Spina, E. Chimienti, F. Martellotta et al., “Phase 2 study of intrathecal, long-acting liposomal cytarabine in the prophylaxis of lymphomatous meningitis in human immunodeficiency virus-related non-Hodgkin lymphoma,” Cancer, vol. 116, no. 6, pp. 1495–1501, 2010. View at Publisher · View at Google Scholar · View at Scopus
  94. A. Re, M. Michieli, S. Casari et al., “High-dose therapy and autologous peripheral blood stem cell transplantation as salvage treatment for AIDS-related lymphoma: long-term results of the Italian Cooperative Group on AIDS and Tumors (GICAT) study with analysis of prognostic factors,” Blood, vol. 114, no. 7, pp. 1306–1313, 2009. View at Publisher · View at Google Scholar · View at Scopus
  95. C. Cattaneo, H. Finel, G. McQuaker, E. Vandenberghe, G. Rossi, and P. Dreger, “Autologous hematopoietic stem cell transplantation for plasmablastic lymphoma: the European society for blood and marrow transplantation experience,” Biology of Blood and Marrow Transplantation, vol. 21, no. 6, pp. 1146–1147, 2015. View at Publisher · View at Google Scholar